SUGAR LAND--March 14, 2018--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--On track to reach a reported $1.2 trillion in product sales by 2022, the global Pharmaceutical Industry's path is a convoluted one. With compound annual growth rates ranging from .05% to near double digits, much depends on which product sector and or region is being considered. While the general consensus is that the most growth is expected from evolving markets such as China and India, the American and European markets still dominate. So, it is no surprise that the top 10 pharmaceutical companies are headquartered in these regions. At least for now.

Login to Read More